Multicenter Post Market Clinical Follow-up (PMCF) study on horizontal ridge augmentation with Geistlich Bio-Graft®

Multicenter Post Market Clinical Follow-up (PMCF) study on horizontal ridge augmentation with Geistlich Bio-Graft® - 10828-018

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00006106

Enrollment

Registered

2014-04-17

Start date

2014-02-17

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ridge width insufficient for implant placement

Interventions

Group 1: horizontal ridge augmentation with Geistlich Bio-Graft

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Need for horizontal ridge augmentation

Exclusion criteria

Exclusion criteria: general contraindications for oral surgery, diseases or medication interfering with bone metabolism or wound healing, pregnancy and lactation, participation in other clinical trials

Design outcomes

Primary

Measure	Time frame
Visual assessment of the possibility of implant placement after 6 months healing	—

Secondary

Measure	Time frame
assessment of gain in ridge width by means of a caliper after 6 months, assessment of adverse events; soft tissue healing during study; peri-implant indexes at final visit;	—

Countries

France, Germany, United Kingdom

Contacts

Public ContactEla Bingel-Erlenmeyer

Geistlich Pharma AG

Ela.Bingel-Erlenmeyer@geistlich.ch+41 41 492 67 07

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026